Reference
1. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013;58:593-608.
2. Zeng F, Guo P, Huang Y, Xin W, Du Z, Zhu S, Deng Y, et al. Epidemiology of hepatitis B virus infection: results from a community-based study of 0.15 million residents in South China. Scientific reports 2016;6:36186.
3. Ramos-Tovar E, Muriel P. Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver. Antioxidants (Basel, Switzerland) 2020;9.
4. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia J, Schwabe R, Brenner D. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. Journal of hepatology 2006;45:429-438.
5. López-Navarrete G, Ramos-Martínez E, Suárez-Álvarez K, Aguirre-García J, Ledezma-Soto Y, León-Cabrera S, Gudiño-Zayas M, et al. Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation. International journal of biological sciences 2011;7:1273-1286.
6. Wang L, Wang Y, Quan J. Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis. Human cell 2020;33:582-589.
7. Thuy L, Hai H, Kawada N. Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis. Clinical and molecular hepatology 2020;26:280-293.
8. McQuitty C, Williams R, Chokshi S, Urbani L. Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment. Frontiers in immunology 2020;11:574276.
9. de Oliveira C, Martins L, de Sousa A, Moraes K, Costa B, Vieira M, Coelho B, et al. Resveratrol increases the activation markers and changes the release of inflammatory cytokines of hepatic stellate cells. Molecular and cellular biochemistry 2020.
10. Amoras E, Monteiro Gomes S, Freitas Queiroz M, de Araújo M, de Araújo M, da Silva Conde S, Ishak R, et al. Intrahepatic interleukin 10 expression modulates fibrinogenesis during chronic HCV infection. PloS one 2020;15:e0241199.
11. Chen H, Awale S, Wu C, Lee H, Wu H. Co-cultured bone marrow mesenchymal stem cells repair thioacetamide-induced hepatocyte damage. Cell biology international 2020;44:2459-2472.
12. Van Campenhout S, Van Vlierberghe H, Devisscher L. Common Bile Duct Ligation as Model for Secondary Biliary Cirrhosis. Methods in molecular biology (Clifton, N.J.) 2019;1981:237-247.
13. Schreuder A, Busch O, Besselink M, Ignatavicius P, Gulbinas A, Barauskas G, Gouma D, et al. Long-Term Impact of Iatrogenic Bile Duct Injury. Digestive surgery 2020;37:10-21.
14. Al-Hashem F, Al-Humayed S, Amin S, Kamar S, Mansy S, Hassan S, Abdel-Salam L, et al. Metformin inhibits mTOR-HIF-1α axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations. Journal of cellular physiology 2019;234:9328-9337.
15. Mardpour S, Hassani S, Mardpour S, Sayahpour F, Vosough M, Ai J, Aghdami N, et al. Extracellular vesicles derived from human embryonic stem cell-MSCs ameliorate cirrhosis in thioacetamide-induced chronic liver injury. Journal of cellular physiology 2018;233:9330-9344.
16. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20:15-20.
17. McGovern A, Vitkovitsky I, Jones D, Mullins M. Can AST/ALT ratio indicate recovery after acute paracetamol poisoning? Clinical toxicology (Philadelphia, Pa.) 2015;53:164-167.
18. Welson N, Rofaeil R, Ahmed S, Gaber S, Batiha G, Shahataa M. Vitamin E protects against gabapentin-induced chronic hepatic and renal damage associated with the inhibition of apoptosis and tissue injury in rats. Life sciences 2021;267:118940.
19. Guo T, Liu Z, Zhao Q, Zhao Z, Liu C. A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo. Acta pharmacologica Sinica 2018;39:1483-1492.
20. Lee Y, Wallace M, Friedman S. Pathobiology of liver fibrosis: a translational success story. Gut 2015;64:830-841.
21. Wynn T, Ramalingam T. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature medicine 2012;18:1028-1040.
22. Yuswan MH, NH AJ, Mohamad H, Keso S, Mohamad NA, Tengku Md Yusoff TS, Ismail NF, et al. Hydroxyproline determination for initial detection of halal-critical food ingredients (gelatin and collagen). Food Chem 2021;337:127762.
23. Rantakari P, Patten D, Valtonen J, Karikoski M, Gerke H, Dawes H, Laurila J, et al. Stabilin-1 expression defines a subset of macrophages that mediate tissue homeostasis and prevent fibrosis in chronic liver injury. Proceedings of the National Academy of Sciences of the United States of America 2016;113:9298-9303.
24. Demirtaş T, Göz E, Karakeçili A, Gümüşderelioğlu M. Combined delivery of PDGF-BB and BMP-6 for enhanced osteoblastic differentiation. Journal of materials science. Materials in medicine 2016;27:12.
25. Idemoto K, Ishima T, Niitsu T, Hata T, Yoshida S, Hattori K, Horai T, et al. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder. Journal of psychiatric research 2021;134:48-56.
26. Barrett A, Evans I, Frolov A, Britton G, Pellet-Many C, Yamaji M, Mehta V, et al. A crucial role for DOK1 in PDGF-BB-stimulated glioma cell invasion through p130Cas and Rap1 signalling. Journal of cell science 2014;127:2647-2658.
27. Nissen L, Cao R, Hedlund E, Wang Z, Zhao X, Wetterskog D, Funa K, et al. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. The Journal of clinical investigation 2007;117:2766-2777.
28. Zhang S, Ma L, Zhao J, You S, Ma X, Ye X, Liu T. The Phenylethanol Glycoside Liposome Inhibits PDGF-Induced HSC Activation via Regulation of the FAK/PI3K/Akt Signaling Pathway. Molecules (Basel, Switzerland) 2019;24.
29. Feng X, Chi G, Wang H, Gao Y, Chen Q, Ru Y, Luo Z, et al. IL-37 suppresses the sustained hepatic IFN-γ/TNF-α production and T cell-dependent liver injury. International immunopharmacology 2019;69:184-193.
30. Shen X, Guo H, Xu J, Wang J. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease. J Cell Physiol 2019;234:18169-18179.
31. Irungbam K, Roderfeld M, Glimm H, Hempel F, Schneider F, Hehr L, Glebe D, et al. Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice. Laboratory investigation; a journal of technical methods and pathology 2020;100:1411-1424.
32. Gu L, Tao X, Xu Y, Han X, Qi Y, Xu L, Yin L, et al. Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway. Toxicology and applied pharmacology 2016;292:19-29.
33. Jin Z, Liu S, Zhan Q, Shao X, Ma J, Pan L. Decoy receptor 3 alleviates hepatic fibrosis through suppressing inflammation activated by NF-κB signaling pathway. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2018;27:441-447.
34. Li X, Zhang H, Pan L, Zou H, Miao X, Cheng J, Wu Y. Puerarin alleviates liver fibrosis via inhibition of the ERK1/2 signaling pathway in thioacetamide-induced hepatic fibrosis in rats. Experimental and therapeutic medicine 2019;18:133-138.
35. Cao S, Zheng B, Chen T, Chang X, Yin B, Huang Z, Shuai P, et al. Semen Brassicae ameliorates hepatic fibrosis by regulating transforming growth factor-β1/Smad, nuclear factor-κB, and AKT signaling pathways in rats. Drug design, development and therapy 2018;12:1205-1213.
36. Cao G, Zhu R, Jiang T, Tang D, Kwan H, Su T. Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling. Phytomedicine : international journal of phytotherapy and phytopharmacology 2019;63:153055.
37. Hosui A, Kimura A, Yamaji D, Zhu B, Na R, Hennighausen L. Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation. The Journal of experimental medicine 2009;206:819-831.
38. Tawfik A, Amin A, Yousef M, El-Sayd N, Elashry H, Elkadeem M, Abd-Elsalam S. IL-1α correlates with severity of hepatitis C virus-related liver diseases. Journal of inflammation research 2018;11:289-295.
39. Prystupa A, Kiciński P, Sak J, Boguszewska-Czubara A, Toruń-Jurkowska A, Załuska W. Proinflammatory Cytokines (IL-1α, IL-6) and Hepatocyte Growth Factor in Patients with Alcoholic Liver Cirrhosis. Gastroenterology research and practice 2015;2015:532615.
40. Batsaikhan B, Lu M, Yeh M, Huang C, Huang C, Lin Z, Chen S, et al. Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C. Journal of the Chinese Medical Association : JCMA 2019;82:277-281.
41. Xia C, Zhu W, Huang C, Lou G, Ye B, Chen F, Chen Z, et al. Genetic polymorphisms of interleukin-6 influence the development of hepatitis B virus-related liver cirrhosis in the Han Chinese population. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2020;84:104331.
42. Guo X, Cen Y, Wang J, Jiang H. CXCL10-induced IL-9 promotes liver fibrosis via Raf/MEK/ERK signaling pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018;105:282-289.
43. Li J, Xue J, Wang D, Dai X, Sun Q, Xiao T, Wu L, et al. Regulation of gasdermin D by miR-379-5p is involved in arsenite-induced activation of hepatic stellate cells and in fibrosis via secretion of IL-1β from human hepatic cells. Metallomics : integrated biometal science 2019;11:483-495.
44. Yao L, Xing S, Fu X, Song H, Wang Z, Tang J, Zhao Y. Association between interleukin-10 gene promoter polymorphisms and susceptibility to liver cirrhosis. International journal of clinical and experimental pathology 2015;8:11680-11684.
45. Wong S, Ting Y, Yong Y, Tan H, Barathan M, Riazalhosseini B, Bee C, et al. Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection. Scandinavian journal of clinical and laboratory investigation 2021:1-13.
46. Swidnicka-Siergiejko A, Wereszczynska-Siemiatkowska U, Siemiatkowski A, Wasielica-Berger J, Janica J, Mroczko B, Dabrowski A. The imbalance of peripheral interleukin-18 and transforming growth factor-β1 levels in patients with cirrhosis and esophageal varices. Cytokine 2019;113:440-445.
47. Mikadze I, Vashakidze E. The serum level of interleukin-12 among patients with HCV infection. Georgian medical news 2011:40-45.
48. Jeong W, Kim J, Bazer FW, Song G, Kim J. Stimulatory effects of interleukin-1 beta on development of porcine uterine epithelial cell are mediated by activation of the ERK1/2 MAPK cell signaling cascade. Mol Cell Endocrinol 2016;419:225-234.
Table 1. Effects of BDL or TAA on the liver fibrosis in rats